Axcelis Technologies (NASDAQ:ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced its preliminary financial results for the second quarter of 2024.

The company expects revenue to exceed $252 million and diluted earnings per share to be greater than $1.38.

This surpasses the previously issued guidance of $245 million in revenue and $1.30 in diluted earnings per share.